SCIENTIFIC LITERATURE

Research literature review

Evidence-focused summaries and references to original scientific publications. Check study design, population, limitations and source material before drawing conclusions.

Research and safety notice: This library is for educational information, not medical advice. Research findings do not establish that a substance is safe or effective for human use. Product status and advertising restrictions vary by substance and jurisdiction. No purchase or treatment recommendation is made on this page.

Retatrutide

Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity

PubMed · 2026-09-29

Authors include Ania M Jastreboff and colleagues. Journal: The New England Journal of Medicine. Publication date: 29 September 2026. PMID: 42814954. DOI: 10.1056/NEJMoa2604169. This clinical trial publication reports research on retatrutide in adults with obesity.

Limitations and interpretation

Trial results apply to the studied participants, intervention and follow-up period. They do not establish suitability for every individual or imply that an investigational product is approved for general use.

Open original source / literature record ↗